Cisco is the dominant vendor in enterprise networking, and under CEO Chuck Robbins, it continues to shake things up. Its most recent mega-acquisition is its $28 billion purchase of Splunk, a bold ...
Cisco will spend between $700 million and $800 million in the first quarter of its 2025 fiscal year. Cisco Systems confirmed massive layoffs Wednesday with plans to cut about 7 percent of its ...
Cisco Systems Inc. agreed to invest in CoreWeave, a cloud-computing provider that’s among the hottest startups in artificial intelligence, as part of a transaction that values the company at $23 ...
Cisco Systems (NASDAQ:CSCO) has agreed to invest in CoreWeave as part of a transaction which values the startup at $23B, Bloomberg News reported, citing people familiar with the matter. Cloud ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
(Reuters) - Cisco Systems is set to invest in CoreWeave, valuing the cloud services provider at $23 billion, according to a Bloomberg News report on Thursday, citing people familiar with the matter.
Cisco EVP and COO Maria Martinez is leaving on the heels of a companywide layoff notice impacting 5 percent of the global workforce, and as Cisco’s pending $28 billion acquisition of Splunk looms.
Oct 3 (Reuters) - (This Oct. 3 story has been corrected to drop reference to CEO Michael Intrator in paragraph 3) Cisco Systems (CSCO.O), opens new tab is set to invest in CoreWeave, valuing the ...
Myelodysplastic syndrome (MDS) can be difficult to diagnose. Many people who are diagnosed with MDS go to their doctor with some or all of the symptoms typical of MDS. Other people are diagnosed with ...
If you have been diagnosed with MDS, you may be able to receive a stem cell transplant, also called a bone marrow transplant. It has the potential to cure MDS. Learn more about our stem cell ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...